Cargando…

Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo

This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Tian, Xu, Lu‐Lu, Guo, Peng‐Yue, Shi, Wan‐Ting, Cheng, Yan‐Qiong, Liu, Ai‐Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944853/
https://www.ncbi.nlm.nih.gov/pubmed/36810974
http://dx.doi.org/10.1002/prp2.1064
_version_ 1784892008728363008
author Xia, Tian
Xu, Lu‐Lu
Guo, Peng‐Yue
Shi, Wan‐Ting
Cheng, Yan‐Qiong
Liu, Ai‐Jun
author_facet Xia, Tian
Xu, Lu‐Lu
Guo, Peng‐Yue
Shi, Wan‐Ting
Cheng, Yan‐Qiong
Liu, Ai‐Jun
author_sort Xia, Tian
collection PubMed
description This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric administration of amlodipine (0.5, 1, 2, and 4 mg/kg), telmisartan (4, 8, and 16 mg/kg), candesartan (1, 2, and 4 mg/kg), nine combinations for amlodipine and telmisartan, and nine combinations for amlodipine and candesartan. The control rats were treated by 0.5% carboxymethylcellulose sodium. Blood pressure was recorded continuously up to 6 h after administration. Both SynergyFinder 3.0 and the probability sum test were used to evaluate the synergistic action. The synergisms calculated by SynergyFinder 3.0 are consistent with the probability sum test both in two different combinations. There is an obviously synergistic interaction between amlodipine and telmisartan or candesartan. The combinations of amlodipine and telmisartan (2 + 4 and 1 + 4 mg/kg) and amlodipine and candesartan (0.5 + 4 and 2 + 1 mg/kg) might exert an optimum synergism against hypertension. Compared with the probability sum test, SynergyFinder 3.0 is more stable and reliable to analyze the synergism.
format Online
Article
Text
id pubmed-9944853
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99448532023-02-23 Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo Xia, Tian Xu, Lu‐Lu Guo, Peng‐Yue Shi, Wan‐Ting Cheng, Yan‐Qiong Liu, Ai‐Jun Pharmacol Res Perspect Original Articles This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric administration of amlodipine (0.5, 1, 2, and 4 mg/kg), telmisartan (4, 8, and 16 mg/kg), candesartan (1, 2, and 4 mg/kg), nine combinations for amlodipine and telmisartan, and nine combinations for amlodipine and candesartan. The control rats were treated by 0.5% carboxymethylcellulose sodium. Blood pressure was recorded continuously up to 6 h after administration. Both SynergyFinder 3.0 and the probability sum test were used to evaluate the synergistic action. The synergisms calculated by SynergyFinder 3.0 are consistent with the probability sum test both in two different combinations. There is an obviously synergistic interaction between amlodipine and telmisartan or candesartan. The combinations of amlodipine and telmisartan (2 + 4 and 1 + 4 mg/kg) and amlodipine and candesartan (0.5 + 4 and 2 + 1 mg/kg) might exert an optimum synergism against hypertension. Compared with the probability sum test, SynergyFinder 3.0 is more stable and reliable to analyze the synergism. John Wiley and Sons Inc. 2023-02-22 /pmc/articles/PMC9944853/ /pubmed/36810974 http://dx.doi.org/10.1002/prp2.1064 Text en © 2023 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Xia, Tian
Xu, Lu‐Lu
Guo, Peng‐Yue
Shi, Wan‐Ting
Cheng, Yan‐Qiong
Liu, Ai‐Jun
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
title Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
title_full Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
title_fullStr Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
title_full_unstemmed Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
title_short Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
title_sort synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using synergyfinder 3.0 and probability sum test in vivo
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944853/
https://www.ncbi.nlm.nih.gov/pubmed/36810974
http://dx.doi.org/10.1002/prp2.1064
work_keys_str_mv AT xiatian synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo
AT xululu synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo
AT guopengyue synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo
AT shiwanting synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo
AT chengyanqiong synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo
AT liuaijun synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo